Summer Street initiates coverage of Salix Pharmaceuticals (NASDAQ: SLXP) with a Buy rating. Price target of $38.

Soleil analyst says ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE